August 31, 2012

Achillon raising $41.8 million in stock deal

Achillion Pharmaceuticals expects to raise $41.8 million through a direct offering of its stock to investors through QVT Financial LP.

The New Haven maker of drugs that fight infectious diseases agreed to sell 6,367,853 shares of its common stock at $6.57 per share. The sale is expected to close Sept. 4.

QVT Financial is based in New York City and has a stock portfolio valued at more than $1 billion.

The direct-to-investor transaction had been filed with and approved by the Securities and Exchange Commission.

Free E-Newsletters

Sign up now for our daily and weekly
e-newsletters! Click Here

Today's Poll Should CT mandate firms disclose more tax data?<>
Most Popular on Facebook
Copyright 2017 New England Business Media